According to GoodRx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.66954. At the end of 2023 the company had a P/S ratio of 3.63.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.63 | 50.58% |
2022 | 2.41 | -86.23% |
2021 | 17.5 | -39% |
2020 | 28.7 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Perion Network PERI | 0.7547 | -79.43% | ๐ฎ๐ฑ Israel |